The Washington Post - February 23, 2020
Nir Barzilai, M.D., explains how age is a risk factor for many diseases, but notes a mix of other factors, including genetics and lifestyle, can extend the years one remains free of serious disease. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
Reuters - February 14, 2020
Michal Melamed, M.D., comments on a study finding that people who exercise may be less likely than those who are sedentary to develop kidney disease. Dr. Melamed is associate professor of medicine and of epidemiology & population health at Einstein and a nephrologist at Montefiore.
Dr. MelamedMore coverage on Dr. Melamed
NPR - February 14, 2020
Margaret Kielian, Ph.D., comments on a pandemic preparedness program the federal government is developing to respond quickly to a disease outbreaks. Dr. Kielian is professor of cell biology and the Samuel H. Golding Chair in Microbiology at Einstein.
US News & World Report - January 28, 2020
A U.S. News & World Report article encourages prospective medical school applicants to read medical school blogs to get a sense of how students and physicians feel about the training process and the practice of medicine. Among the blogs named was The Doctor's Tablet, Einstein's award-winning blog featuring posts by faculty, researchers, physicians, and current students. The blog’s co-editors are Gordon Earle, associate dean for communications and public affairs, and David Flores, director of social media.
US News & World Report - January 27, 2020
Michael Lipton, M.D., Ph.D., explains his published research suggesting that a gene variant, APOE-e4, increases the risk for cognitive impairment among amateur soccer players who most frequently head the ball. Dr. Lipton is professor of radiology and associate director of the Gruss Magnetic Resonance Research Center at Einstein, and director of MRI Services at Montefiore.
More CoverageDr. Lipton's ProfileMore coverage on Dr. Lipton
NPR - January 2, 2020
William Jacobs Jr., Ph.D., comments on a study in which high doses of the tuberculosis vaccine injected directly into the bloodstream of monkeys provided nearly complete immunity to the disease. Dr. Jacobs is professor of microbiology & immunology and of genetics and the Leo and Julia Forchheimer Chair in Microbiology & Immunology at Einstein.
Dr. Jacobs' ProfileMore coverage on Dr. Jacobs
US News & World Report - December 31, 2019
Sarah Baron, M.D., comments on her study that found nearly one in 10 patients admitted to the hospital are already infected with Clostridioides difficile, a bacterium that causes severe diarrhea and 30,000 deaths each year in the U.S. and has long been thought to be acquired while in the hospital. Dr. Baron is assistant professor of medicine at Einstein and an internist at Montefiore.
Dr. Baron's Profile
The Guardian - December 21, 2019
Nir Barzilai, M.D., describes his planned clinical trial that will study the effects of metformin, a drug used to treat diabetes, on aging. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
The Washington Post - December 19, 2019
Lisa Shulman, M.D., comments on her research that found most children who “lose” an autism diagnosis continue to need therapeutic and educational support for language and learning disabilities and emotional and behavioral problems. Dr. Shulman is professor of pediatrics at Einstein and interim director of the Rose F. Kennedy Children’s Evaluation and Rehabilitation Center at Montefiore.
Dr. Shulman's ProfileMore coverage on Dr. Shulman
Associated Press - December 18, 2019
Aaron Fox, M.D., M.S., is leading a study to determine if a “medication-first” approach to treating opioid use disorder, which uses buprenorphine to control withdrawal symptoms, is more effective than the current standard of care, which focuses on counseling. Dr. Fox is associate professor of medicine at Einstein and an internist at Montefiore.
Dr. Fox's Faculty Profile
Science - December 14, 2019
Aristea Galanopoulou, M.D., Ph.D., is studying traumatic brain injuries to find biomarkers that may indicate who is at increased risk of developing epilepsy. Dr. Galanopoulou is professor in the Saul R. Korey Department of Neurology and in the Dominick P. Purpura Department of Neuroscience at Einstein and a neurologist at Montefiore.
Dr. Galanopoulou's Profile
The New York Times - December 14, 2019
Elina Jerschow, M.D., M.S., who studies adverse reactions to medications, diagnosed a patient with aspirin-exacerbated respiratory disease (AERD) after the patient suffered a severe asthma attack and developed a severe reaction to select pain medications. Dr. Jerschow is associate professor of medicine and of microbiology & immunology at Einstein and director of the Montefiore AERD and Drug Allergy Center.
Dr. Jerschow's ProfileMore coverage on Dr. Jerschow
November 21, 2018
Genetic Engineering & Biotechnology News quotes Ulrich Steidl, M.D., Ph.D., about his recent research on cancer stem cells that lead to myeloid leukemia. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research, director of the Stem Cell Isolation and Xenotransplantation Facility and a professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
January 6, 2015
Chemical & Engineering News highlights research by Peng Wu, Ph.D. and Ben Ovryn, Ph.D., who devised a way to track the movement of single glycoprotein molecules on the surfaces of living cancer cells. Dr. Wu is associate professor of biochemistry and Dr. Ovryn is associate professor of anatomy and structural biology.
Dr. Wu's Profile
February 5, 2013
Chemical & Engineering News interviews David Cowburn, Ph.D., about conflicting reports on the efficacy of stapled peptides, protein fragments chemically locked into an α-helical shape, and their potential for drug development. Dr. Cowburn, who has used stapled peptides to interfere with HIV assembly, notes that stapling is not easy and many adjustments need to be made to create a peptide that will work successfully within a cell. Dr. Cowburn is professor of biochemistry and of physiology & biophysics.
Dr. Cowburn's Profile
December 13, 2012
MedPage Today interviews Roy Chuck, M.D., Ph.D., about a study demonstrating a large increase in vision loss in the past decade, likely from diabetes. Dr. Chuck points out that vision loss in the young – those aged 22-39 – saw a significant increase, which is an indicator that damage to their eyes began when they were still children. Dr. Chuck is chair of ophthalmology & vision services at Einstein and Montefiore Medical Center.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
October 24, 2012
Nature.com interviews Scott Emmons, Ph.D., about his study that determined the complete neural diagram that governs male roundworm mating behavior. Dr. Emmons notes that his lab took the unusual but important step of measuring the strength of each neural connection, instead of simply counting the number of synapses. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience and the Siegfried Ullmann Chair in Molecular Genetics.
More CoverageDr. Emmons' ProfileMore coverage on Dr. Emmons
August 27, 2012
American Medical News interviews Robert Marion, M.D., about prenatal whole genome sequencing, which can identify an unborn child’s risk of developing chronic diseases. Because this new test will provide detailed information on mutations of 20,000 to 25,000 genes, some of which will not be significant, Dr. Marion stresses the importance of preparing healthcare professionals to counsel expectant parents about the results. Dr. Marion is director of Einstein’s Children's Evaluation and Rehabilitation Center and chief of developmental medicine at Einstein and Montefiore Medical Center.
Dr. Marion's ProfileMore coverage on Dr. Marion
April 25, 2012
The Journal of the National Cancer Institute interviews Geoffrey Kabat, Ph.D., on the difficulty of proving the link between bishpenol A (BPA), a common chemical in homes and food containers, and cancer risk. Dr. Kabat notes that politics can trump science when enormous public concern exists about an issue, particularly when it potentially effects infants, like BPA. Dr. Kabat is a senior epidemiologist at Einstein.
March 13, 2012
New Scientist interviews Vern Schramm, Ph.D., about his research on transition state analogs, a class of drugs he has been developing that target and neutralize specific enzymes in order to combat disease. Dr. Schramm is professor and Ruth Merns Chair in Biochemistry at Einstein.
Dr.Schramm's ProfileMore coverage on Dr.Schramm
February 1, 2012
Arthritis Today interviews Dr. Anna Broder regarding her research that found continued treatment may help extend the lives of lupus patients with end-stage renal disease. Dr. Broder is assistant professor of medicine.
Dr.Broder's ProfileMore coverage on Dr.Broder
Newsweek - February 1, 2012
Microbe features research by Liise-Anne Pirofski , M.D., about a newly identified antibody that works against pneumococcal bacteria and could help to improve vaccines against pneumonia. Dr. Pirofski is chief of the division of infectious diseases at Einstein and Montefiore Medical Center and the Selma and Dr. Jacques Mitrani Professor in Biomedical Research.
Dr.Pirofski's ProfileMore coverage on Dr.Pirofski